Introduction An important shortcoming in contemporary biomedical research has been the lack of substantive progress in reducing the cost and time, while ultimately increasing the success rate of drug discovery. In spite of the many advances in technology and basic understanding over the past decade, surprisingly little increase has occurred in the number of new drugs available. This problem has resulted in the longstanding and continuing reality in the pharmaceutical industry that new drugs coming into the marketplace are often mere modifications of existing chemical entities (“me too drugs”), rather than truly novel compounds that are actually optimal or unique to the target of interest. The revolutionary advances in combinatorial chemistry over the past 20 years now enable extremely large numbers of individual compounds to be synthesized. This has fostered a simple volume-driven approach not greatly different from that utilized for the past 50 years, but which in turn has several of its own challenges. The first involves the extremely large number, manner and format of compounds to be prepared and screened. The second involves the type(s) of assays with which these compounds can or should be used, and how the compounds should be tested in such assays. Both of these factors typically hamper academic and non-profit research organizations. It started with peptides! Over the course of the past 20 years, our group has been consistently working toward the development of new techniques to discover simple solutions or approaches to complicated concepts or methodologies. To this end, we have directed our efforts toward the conception and development of novel approaches that permit the simplification of synthetic and screening processes of value to the drug discovery process. These efforts have resulted in the development of five key technologies: (1) the “tea bag” method for solid phase synthesis [1]; (2) the use of “mixture-based” combinatorial libraries to identify highly active individual compounds from literally millions of others [2]; (3) the use of “positional scanning” approaches for the rapid identification of individual compounds from highly diverse mixture-based combinatorial libraries [3]; (4) the “libraries from libraries” method for the generation of very large acyclic and heterocyclic combinatorial mixture-based libraries [4]; and (5) the solid phase synthesis on “volatilizable” solid supports and linkers that can be completely removed by their ultimate decomposition and ultimate “volatilization” during the final cleavage step of the synthetic process [5].
[1]
R. Houghten.
General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
,
1985,
Proceedings of the National Academy of Sciences of the United States of America.
[2]
R A Houghten,et al.
Mixture-based synthetic combinatorial libraries.
,
1999,
Journal of medicinal chemistry.
[3]
R. Houghten,et al.
Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery
,
1991,
Nature.
[4]
R A Houghten,et al.
Peptide libraries: Determination of relative reaction rates of protected amino acids in competitive couplings
,
1994,
Biopolymers.
[5]
Yongping Yu,et al.
"Volatilizable" supports for high-throughput organic synthesis.
,
2005,
Journal of the American Chemical Society.
[6]
Yongping Yu,et al.
Combinatorial chemistry: libraries from libraries, the art of the diversity-oriented transformation of resin-bound peptides and chiral polyamides to low molecular weight acyclic and heterocyclic compounds.
,
2004,
The Journal of organic chemistry.
[7]
Clemencia Pinilla,et al.
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.
,
2004,
Cancer cell.
[8]
R A Houghten,et al.
Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins.
,
2009,
International journal of peptide and protein research.
[9]
Richard A. Houghten.
Soluble Combinatorial Libraries: Extending the Range and Repertoire of Chemical Diversity
,
1994
.
[10]
Clemencia Pinilla,et al.
Peptidic complex mixtures as therapeutic agents in CNS autoimmunity.
,
2004,
Molecular immunology.
[11]
R A Houghten,et al.
"Libraries from libraries": chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity.
,
1994,
Proceedings of the National Academy of Sciences of the United States of America.
[12]
R A Houghten,et al.
Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries.
,
1992,
BioTechniques.
[13]
C. Dooley,et al.
New opioid peptides, peptidomimetics, and heterocyclic compounds from combinatorial libraries.
,
1999,
Biopolymers.